Cost–effectiveness of overactive bladder treatments: from the US payer perspective - Concepedia

Concepedia

Publication | Open Access

Cost–effectiveness of overactive bladder treatments: from the US payer perspective

DOI Full Paper Access

35

Citations

25

References

2018

Year

Brian Murray, Sam Hessami, Dmitry Gultyaev, J. Lister, Roger R. Dmochowski, Kristin Khalaf Gillard, Sanja Stanisic, Amy Tung, Steven A. Kaplan

Journal of Comparative Effectiveness Research

Abstract

Compared with BSC, onabotA 100U was the most cost-effective treatment option for patients with refractory OAB.

References

	Year	Citations
Markov Models in Medical Decision Making Frank A. Sonnenberg, J. Robert Beck Medical Decision Making EngineeringPrognosisMarkov Decision ProcessesDiscrete-event SimulationHospital Medicine	1993	2.4K
Prevalence and burden of overactive bladder in the United States Walter F. Stewart, J. Van Rooyen, Geoffrey W. Cundiff, World Journal of Urology Substance AbuseUrologyUrological ResearchUrologic Cancer EpidemiologyVoiding Dysfunction	2003	2.2K
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline E. Ann Gormley, Deborah J. Lightner, Kathryn L. Burgio, The Journal of Urology	2012	697
Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial Kenneth M. Peters, Donna J. Carrico, Ramon Perez-Marrero, The Journal of Urology	2010	470
OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial Christopher R. Chapple, Karl‐Dietrich Sievert, Scott MacDiarmid, European Urology Urological ResearchUrologyVoiding DysfunctionUrinary IncontinencePlacebo-controlled Trial	2013	401
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial Victor W. Νitti, Roger R. Dmochowski, Sender Herschorn, The Journal of Urology	2012	399
OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women Cindy L. Amundsen, Holly E. Richter, Shawn A. Menefee, JAMA	2016	217
Percutaneous Tibial Nerve Stimulation for the Long-Term Treatment of Overactive Bladder: 3-Year Results of the STEP Study Kenneth M. Peters, Donna J. Carrico, Christopher J. Miller, The Journal of Urology	2012	202
Probabilistic Sensitivity Analysis for Decision Trees with Multiple Branches: Use of the Dirichlet Distribution in a Bayesian Framework Andrew Briggs, A. E. Ades, Martin Price Medical Decision Making	2003	189
Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation Steven Siegel, Karen Noblett, Jeffrey Mangel, Urology Urological ResearchUrologyVoiding DysfunctionThree-year Follow-up ResultsNeuromodulation Therapies	2016	125

Page 1